Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.
Clinical trial NCT04027192 · COMPLETED
Trial details
- NCT number
- NCT04027192
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-31
- Primary completion
- 2020-09-11
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.